Document de presse | 2022.02.02
Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of anti-HIV-1[1] antibodies by applying cutting-edge microscopy techniques to in vitro viral cultures. The scientists found that certain antibodies already known for effectively targeting HIV-1 envelope (Env) protein can prevent infected cells from releasing viral particles...
Document de presse | 2022.03.29
The SARS-CoV-2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. Although Omicron is responsible for less severe forms in the general population, immunocompromised people are still at higher risk of developing severe forms of COVID-19. Several monoclonal antibodies are currently available in clinical practice as a preventive treatment for these patients....
Document de presse | 2022.04.12
A very small percentage of people with HIV-1, known as "post-treatment controllers" (PTCs), are able to control their infection after interrupting all antiretroviral therapy.Understanding the fundamental mechanisms that govern their immune response is essential in order to develop HIV-1 vaccines, novel therapeutic strategies to achieve remission, or both.A recent study investigated the humoral...
News | 2022.06.14
Malaria is a disease that continues to cause tremendous suffering and mortality in the tropics. This disease is caused by Plasmodium parasites. The species Plasmodium falciparum causes the severest and most deadly form of malaria. Scientists from Institut Pasteur studied the blood stage of the parasites and found a mechanism which could lead to new and efficient drugs against Malaria.Despite...
Article | 2024.04.30
Veterinarian and biologist, this disciple of Louis Pasteur pioneered the study of microbial animal diseases and is considered the founder of veterinary microbiology.
News | 2022.07.09
Institut Pasteur Senior Executive Scientific Vice-President Christophe d'Enfert provides a brief, cross-disciplinary overview of 2021 covering capacity building, enhanced partnerships and future technologies.
News | 2025.12.18
Several pathogens have adapted to winter conditions and circulate on a seasonal basis in the northern hemisphere. These include seasonal influenza viruses, currently under heightened surveillance; viruses responsible for bronchiolitis in infants; and coronaviruses. Only a handful of the hundreds of respiratory and stomach viruses in circulation cause significant winter epidemics.
Article | 2023.12.18
This interdisciplinary programme, funded by ECDC, combines lectures and practical sessions delivered by multiple host institutions in order to enhance surveillance, preparedness, and readiness to respond to outbreaks.
News | 2022.06.08
A lesser known but equally crucial dimension in managing and responding to an epidemic is social sciences in health, which can shed light on populations' understanding, perception and acceptance of the risks associated with diseases. The COVID-19 pandemic is no exception. As the disease spread across the planet, clear differences in perception by populations were observed in different countries,...
Article | 2016.12.09
Tuition fees vary according to the length of the course.2nd year Masters students from the Greater Paris universities (Université de Paris, Paris-Saclay and Sorbonne Université) attending courses covered by agreements with the Institut Pasteur and other students from these universities attending courses as part of a doctoral module are exempt from fees.The "Student" rate applies upon...